These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2436013)

  • 1. Unusual opioid withdrawal syndrome. A case-report.
    Kumor KM; Grochow LB; Hausheer F
    Lancet; 1987 Mar; 1(8535):720-1. PubMed ID: 2436013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is withdrawal hyperalgesia in morphine-dependent mice a direct effect of a low concentration of the residual drug?
    Rubovitch V; Pick CG; Sarne Y
    Addict Biol; 2009 Sep; 14(4):438-46. PubMed ID: 19489750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer.
    Sykes NP
    Palliat Med; 1996 Apr; 10(2):135-44. PubMed ID: 8800821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre.
    Jittiwutikarn J; Ali R; White JM; Bochner F; Somogyi AA; Foster DJ
    Br J Clin Pharmacol; 2004 Nov; 58(5):536-41. PubMed ID: 15521902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opium tincture versus methadone syrup in management of acute raw opium withdrawal: A randomized, double-blind, controlled trial.
    Tabassomi F; Zarghami M; Shiran MR; Farnia S; Davoodi M
    J Addict Dis; 2016; 35(1):8-14. PubMed ID: 26566681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice.
    Bilbao A; Cippitelli A; Martín AB; Granado N; Ortiz O; Bezard E; Chen JF; Navarro M; Rodríguez de Fonseca F; Moratalla R
    Psychopharmacology (Berl); 2006 Apr; 185(2):160-8. PubMed ID: 16470403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast).
    Hutchinson MR; Lewis SS; Coats BD; Skyba DA; Crysdale NY; Berkelhammer DL; Brzeski A; Northcutt A; Vietz CM; Judd CM; Maier SF; Watkins LR; Johnson KW
    Brain Behav Immun; 2009 Feb; 23(2):240-50. PubMed ID: 18938237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Opioid treatment of pain in angina pectoris].
    Hermann CK; Eriksen J
    Ugeskr Laeger; 2002 Apr; 164(17):2297-8. PubMed ID: 11989181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opium Withdrawal Delirium: Two Case Reports.
    Sharma RC; Kumar R; Sharma DD; Kanwar P
    Psychopharmacol Bull; 2017 Jan; 47(1):48-51. PubMed ID: 28138205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare presentation of intrathecal morphine withdrawal psychosis.
    Aiyer R; Jain V; Bhatia A; Mekinulov B; Gungor S
    Pain Manag; 2017 May; 7(3):171-173. PubMed ID: 28326948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.
    Setnik B; Roland CL; Goli V; Sommerville K; Webster L
    J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Practical problems associated with long-term opioid therapy].
    Bell RF
    Tidsskr Nor Laegeforen; 1997 May; 117(12):1786-7. PubMed ID: 9213988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
    Tsui BC; Davies D; Desai S; Malherbe S
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of sustained release oral morphine as a bridge in withdrawal of morphine in patients on high doses of oral immediate release morphine for cancer pain.
    Ahmed A; Khurana H; Gogia V; Mishra S; Bhatnagar S
    Am J Hosp Palliat Care; 2010 Sep; 27(6):413-5. PubMed ID: 20220200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of methadone.
    Layson-Wolf C; Goode JV; Small RE
    J Pain Palliat Care Pharmacother; 2002; 16(1):29-59. PubMed ID: 14650449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide.
    Lewanowitsch T; Miller JH; Irvine RJ
    Life Sci; 2006 Jan; 78(7):682-8. PubMed ID: 16102783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
    Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
    J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.